Results 241 to 250 of about 134,438 (269)

Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort. [PDF]

Breast
Lee J, Bae SJ, Kim HK, Nam SJ, Kim HJ, Bae SY, Park HY, Ko BK, Park JH, Kwon Y, Park Y, Baek SH, Kook Y, Kim S, Lim YA, Kang HJ, Kim D, Jeong J, Ahn SG.   +18 more
europepmc   +1 more source

Differential Expression/Regulation of Progesterone Receptor in Reproductive Tissues (Ovary and Uterus) Induced by Human Chorionic Gonadotropin and Equine Chorionic Gonadotropin Treatments in Sows. [PDF]

Anat Histol Embryol
León OC, Anzaldúa Arce SR, Cornejo Cortes MA, Cerbón M, Castañeda FEM, Arvizu RU, Trujillo Ortega ME.   +6 more
europepmc   +1 more source

The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors. [PDF]

Cancers (Basel)
Guliyev M, Güren AK, Özge E, Çolak R, Majidova N, Alkan Şen G, Safarov S, Günaltılı M, Fidan MC, Gültürk İ, Yılmaz M, Bayoğlu İV, Demirci NS, Alan Ö.   +13 more
europepmc   +1 more source

Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity. [PDF]

J Xenobiot
Barata IS, Rueff J, Kranendonk M, Esteves F.   +3 more
europepmc   +1 more source

Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma. [PDF]

Dis Markers
Hashmi AA, Mallick BA, Rashid K, Malik UA, Zia S, Zia F, Irfan M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly